scispace - formally typeset
R

Robert Fagard

Researcher at Katholieke Universiteit Leuven

Publications -  788
Citations -  109235

Robert Fagard is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 114, co-authored 787 publications receiving 104613 citations.

Papers
More filters
Journal ArticleDOI

Corticosteroids contribute to muscle weakness in chronic airflow obstruction.

TL;DR: In patients with COPD or asthma, respiratory and peripheral muscle strength and steroid treatment are interrelated despite the relatively low doses administered, demonstrating further limitations on the prolonged treatment of chronic airflow obstruction with systemic corticosteroids.
Journal ArticleDOI

Induction of cardiac fibrosis by transforming growth factor-beta(1).

TL;DR: The role of transforming growth factor-beta(1) in the production and deposition of collagens and in the induction of gene expression in the myocardium in relation to the development of myocardial fibrosis will be discussed.
Journal ArticleDOI

Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis.

TL;DR: A meta-analysis indicates that the incidence of cardiovascular events is not significantly different between WCHT and true normotension, whereas the outcome is worse in patients with masked or sustained hypertension.
Journal ArticleDOI

Effect of resistance training on resting blood pressure: a meta-analysis of randomized controlled trials.

TL;DR: The results suggest that moderate intensity resistance training is not contraindicated and could become part of the non-pharmacological intervention strategy to prevent and combat high blood pressure, however, additional studies are needed, especially in the hypertensive population.
Journal ArticleDOI

‘European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)’ The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). [Eur Heart J 2012;33:1635–1701, doi: 10.1093/eurheartj/ehs092]